Issue 18, 2017

Tissue chips – innovative tools for drug development and disease modeling

Abstract

The high rate of failure during drug development is well-known, however recent advances in tissue engineering and microfabrication have contributed to the development of microphysiological systems (MPS), or ‘organs-on-chips’ that recapitulate the function of human organs. These ‘tissue chips’ could be utilized for drug screening and safety testing to potentially transform the early stages of the drug development process. They can also be used to model disease states, providing new tools for the understanding of disease mechanisms and pathologies, and assessing effectiveness of new therapies. In the future, they could be used to test new treatments and therapeutics in populations – via clinical trials-on-chips – and individuals, paving the way for precision medicine. Here we will discuss the wide-ranging and promising future of tissue chips, as well as challenges facing their development.

Graphical abstract: Tissue chips – innovative tools for drug development and disease modeling

Article information

Article type
Critical Review
Submitted
28 4月 2017
Accepted
03 8月 2017
First published
10 8月 2017

Lab Chip, 2017,17, 3026-3036

Tissue chips – innovative tools for drug development and disease modeling

L. A. Low and D. A. Tagle, Lab Chip, 2017, 17, 3026 DOI: 10.1039/C7LC00462A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements